Rachel Andes
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Singh, Arun D
AL, NCT05844982: Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Recruiting
3
600
US
Faricimab, fluocinolone acetonide
Jaeb Center for Health Research, National Eye Institute (NEI), National Institutes of Health (NIH), Alimera Sciences, Genentech, Inc.
Radiation Retinopathy, Visual Impairment
11/26
11/28
RINGSIDE, NCT04871282 / 2020-005833-34: A Study of AL102 in Patients With Progressing Desmoid Tumors

Active, not recruiting
2/3
192
Europe, US, RoW
AL102, Placebo
Ayala Pharmaceuticals, Inc,
Desmoid, Desmoid Tumor
01/25
02/25
NCI-2018-01517, NCT03623854: Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Completed
2
10
US
Nivolumab, BMS-936558, MDX-1106, NIVO, ONO-4538, Opdivo, Relatlimab, BMS-986016, BMS986016, Immunoglobulin G4, Anti-(human Lymphocyte Activation Gene-3 Protein) (Human Heavy Chain), Disulfide with Human Light Chain, Dimer
Jonsson Comprehensive Cancer Center, Bristol-Myers Squibb
Chordoma, Locally Advanced Chordoma, Metastatic Chordoma, Unresectable Chordoma
09/23
09/23
NCT05957367: A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Recruiting
1/2
94
US
DCC-3116, Ripretinib, QINLOCK, DCC-2618
Deciphera Pharmaceuticals LLC, Pfizer
GIST
03/27
06/27

Download Options